Status Approved
First Submitted Date
2019/10/14
Registered Date
2019/10/18
Last Updated Date
2020/01/18
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0004351 |
---|---|
Unique Protocol ID | KC19MESI0573 |
Public/Brief Title | A study of postoperative recovery between intravenous anesthesia group and inhalation anesthesia using sevoflurane group after hand assisted laparoscopic donor nephrectomy in living donors for kidney transplantation |
Scientific Title | Comparison of early postoperative recovery between propofol and sevoflurane anesthesia based on intrathecal morphine pain control in living kidney donors undergoing hand assisted laparoscopic nephrectomy: a prospective randomized study |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | KC19MESI0573 |
Approval Date | 2019-10-07 |
Institutional Review Board Name | Catholic Medical Center Clinical Reseach Coordinating Center |
Institutional Review Board Address | 222, Banpo-daero, Seocho-gu, Seoul |
Institutional Review Board Telephone | 02-2258-8202 |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Minsuk Chae |
Title | Dr |
Telephone | +82-2-2258-6150 |
Affiliation | The Catholic University of Korea, Seoul St. Mary's Hospital |
Address | 222 BANPO-DAERO, SEOCHO-GU, SEOUL |
Contact Person for Public Queries | |
Name | Minsuk Chae |
Title | Dr |
Telephone | +82-2-2258-6150 |
Affiliation | The Catholic University of Korea, Seoul St. Mary's Hospital |
Address | 222 BANPO-DAERO, SEOCHO-GU, SEOUL |
Contact Person for Updating Information | |
Name | Minsuk Chae |
Title | Dr |
Telephone | +82-2-2258-6150 |
Affiliation | The Catholic University of Korea, Seoul St. Mary's Hospital |
Address | 222 BANPO-DAERO, SEOCHO-GU, SEOUL |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Recruiting | |
Date of First Enrollment | 2019-10-18 Actual | |
Target Number of Participant | 80 | |
Primary Completion Date | 2021-12-31 , Anticipated | |
Study Completion Date | 2021-12-31 , Anticipated | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | The Catholic University of Korea, Seoul St. Mary's Hospital | |
Recruitment Status | Recruiting | |
Date of First Enrollment | 2019-10-18 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | The Catholic University of Korea, Seoul St. Mary's Hospital |
Organization Type | Medical Institute |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | The Catholic University of Korea, Seoul St. Mary's Hospital |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | Postoperative recovery is one of the important factors in organ donors. They undergo the operation in purpose of the organ donation itself, not because of disease, fast recovery and discharge are necessary in psychological aspects in addition to the physical aspect of the donor. The purpose of this study is to evaluate the difference of degree of recovery between two groups of patients with different anesthetic drugs who get pain relief with morphine by spinal anesthesia. This will be an important data in the future for the rapid recovery and reduced complications of patients undergoing renal donation operation. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Supportive Care |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Single |
Blinded Subject | Subject |
Allocation | RCT |
Intervention Type | Drug |
Intervention Description | One group of patients undergoing general anesthesia was given continuous IV (intravenous) infusion of propofol to the effect site concentration of 3 to 5 mcg/ml using TCI (target controlled infusion) until the end of the operation. The control group received 2 to 3 vol% (1 MAC) of Sevoflurane via endotracheal tube until the end of the operation. |
Number of Arms | 2 |
Arm 1 |
Arm Label Propofol Total intravenous anesthesia |
Target Number of Participant 40 |
|
Arm Type Experimental |
|
Arm Description Continuous infusion of Propofol IV to the effect site concentration of 3 to 5 mcg/ml using TCI until the end of the operation |
|
Arm 2 |
Arm Label Sevoflurane Inhalation anesthesia |
Target Number of Participant 40 |
|
Arm Type Active comparator |
|
Arm Description Maintain 2 to 3 vol% (1 MAC) of Sevoflurane via endotracheal tube until the end of the operation. |
9. Subject Eligibility
Condition(s)/Problem(s) |
Not Applicable-Anesthesia
American Society of Anesthesiologists' physical status 1 or 2 grade |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 19Year~No Limit |
|
Description 1. Healthy donors scheduled to undergo kidney donation at Seoul St. Mary's Hospital 2. Donors who can be administered intrathecal morphine 3. Adults (ages 19 years or older) 4. American Society of Anesthesiologists physical status 1 or 2 grade |
|
Exclusion Criteria |
1. Patients who do not agree to participate in this study 2. Emergency surgery 3. Patient contraindicated for spinal puncture 4. Children (under 19 years old) 5. American Society of Anesthesiologists' physical status 3 or 4 grade 6. Intraoperative bleeding requires colloid or transfusion during surgery 7. Hemodynamic instability to the extent that vasoactive drugs are necessary. |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | Not applicable | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Result of quality of recovery-40 questionnaire for 24 hours after the operation |
|
Timepoint | 24 hours after the operation |
|
Secondary Outcome(s) 1 | ||
Outcome | Total number of steps for 24 hours after operation |
|
Timepoint | 24 hours after the operation |
|
Secondary Outcome(s) 2 | ||
Outcome | Availability of early ambulation on the day of the operation |
|
Timepoint | 6 hours after the operation |
|
Secondary Outcome(s) 3 | ||
Outcome | Complications occurs for 24 hours after the operation |
|
Timepoint | 6 hours and 24 hours after the operation |
|
Secondary Outcome(s) 4 | ||
Outcome | Total dose of IV PCA infused for 6 hours and 24 hours after the operation |
|
Timepoint | 6 hours and 24 hours after the operation |
|
Secondary Outcome(s) 5 | ||
Outcome | Availability of ambulation on the day after the operation |
|
Timepoint | 24 hours after the oparation |
|
Secondary Outcome(s) 6 | ||
Outcome | Frequency and amount of acute pain control medicine administered for 24 hours after the operation |
|
Timepoint | 24 hours after the operation |
|
Secondary Outcome(s) 7 | ||
Outcome | Blood test results preoperative and 6 hours, 24 hours after the operation |
|
Timepoint | The day before and 6 hours, 24 hours after the operation |
|
Secondary Outcome(s) 8 | ||
Outcome | Clavien-Dindo surgical complication grade |
|
Timepoint | 24 hours after the oparation |
|
Secondary Outcome(s) 9 | ||
Outcome | Todal hospital stay |
|
Timepoint | After discharge |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동